ATS 2019 Virtual Final Program

P591 Cardiac Output in Preterm Infants Using Electrical Cardiometry/ R. Ow, J. Van De Water, A. Bozeman, B. Smith-Weaver, M. Rodriguez, B. Ho, D.W. Ashley, Macon, GA, p.A1892 P592 Airway Platelet-Activating Factor Receptor Expression Is Increased in Neonates/ L. Miyashita, G. Foley, N.M. Liu, E. McCamlie, M. Idris, J.M. Grigg, London, United Kingdom, p.A1893 P593 Characterization of the Nasal Transcriptome in Children with Respiratory Syncytial Virus Bronchiolitis/ G. Hahn, S. Schmakel, K. Anekalla, R. Verma, H. Abdala-Valencia, K. Nam, D.R. Winter, B. Coates, K.M. Ridge, Chicago, IL, p.A1894 P594 Clinical and Non-Invasive Lung Imaging Predictors of Respiratory Hospitalizations During the First Year of Life in Infants Born Very Premature/ G.R. Nino, M.A. Arroyo Morr, A. Mansoor, G.F. Perez, M. Said, X. Xu Chen, J. Weinstock, M.G. Linguraru, Washington, DC, p.A1895 P595 Dexamethasone Alters Tracheal Aspirate T-Cell Phenotype in Ventilated Preterm Infants/ E. Patel, C.D. Richardson, S.Z. Yazdi, K.T. Hardy, J.E. Baatz, J. Mulligan, R.M. Ryan, Charleston, SC, p.A1896 P596 Maternal Exposure of Mice to Benzo[a]pyrene (BP) Leads to Potentiation of Neonatal Hyperoxic Lung Injury and Dysbiosis of Intestinal Microbiome: Potential Role of Gut-Lung Axis?/ K. Lingappan, A. Veith, W. Jiang, P. Maturu, X.I. Couroucli, B. Moorthy, Houston, TX, p.A1897 P597 Dynamic PEEP Study: A Non-Invasive Diagnostic Exam to Assess for Effective PEEP in Fragile Children with Severe BPD/ C. Montoya, R.H. Steinhorn, M. Said, G.F. Perez, Washington, DC, p.A1898 P598 Safety and Efficacy of Aerosolized Albuterol in Mechanically Ventilated Infants with Severe Bronchopulmonary Dysplasia/ N. Napolitano, K. Dysart, H. Zhang, H.B. Panitch, E. Jensen, Philadelphia, PA, p.A1899 P599 Association Between Type 1 Laryngeal Cleft and Protracted Bacterial Bronchitis in Children/ T.-A. Ha, J. Ongkasuwan, W. Zhang, S. Das, Houston, TX, p.A1900 Facilitator : G.F. Perez, MD, Washington, DC P600 Profile of Pulmonary Function Parameters in Healthy School Going Children - A South Indian Study/ K.C. Bolla, N. Meenakshi, A. Shanmuganathan, N. Ganga, Kelambakkam, India, p.A1901 P601 Lung Nodules in Pediatrics: Presentation, Evaluation and Diagnosis/ L. Greenawald, C. Seehusen, A.R. Shenoy, Wilmington, DE, p.A1902 P602 Utility of Diagnostic Testing in Incidental Pulmonary Nodules in Children/ A. Barber, C. Gatcliffe, P.J. Passarelli, Z.D. Dworsky, J. Ryu, D.J. Lesser, San Diego, CA, p.A1903 P603 How Safe Is Flexible Bronchoscopy? Six Years of Pediatric Bronchoscopy Outcomes/ E.M. DeBoer, P. Houin, E. Towler, G. Kerby, P.C. Stillwell, Aurora, CO, p.A1904 P604 Clinical Outcomes in Patients with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome at a Single Center/ N. Kataria, I. Randhawa, E. Nussbaum, T. Morphew, K. Singh, T.W. Chin, C. Shahriary, Long Beach, CA, p.A1905 P605 The Management of Pseudomonas Aeruginosa During Concurrent Non-Tuberculous Mycobacteria Treatment in Cystic Fibrosis/ C.M. Oermann, E. Meier, E.C. Elson, Kansas City, MO, p.A1906 P606 Staphylococcus Aureus Infection in Cystic Fibrosis: Single Center Experience/ M. Dahabreh, Z. Sharadga, N. Abaddi, Amman, Jordan, p.A1907 P607 Factors Impacting a “New Baseline” Lung Function in Pediatric Patients with Cystic Fibrosis/ C. Shipp, G.L. McPhail, J. Weiland, L. Mullen, C. Siracusa, Cincinnati, OH, p.A1908 P608 Immune Response to Pneumococcal Polysaccharide Vaccine in Children with Sickle Cell Disease/ C. Flores Oria, J.M. Stark, C.K. Jon, R.A. Mosquera, K. McBeth, H. Emanuel, A. Yadav, Houston, TX, p.A1909 Facilitator : S.M. Paranjape, MD, Baltimore, MD P609 Glucose Control and Lung Function Recovery During Acute Pulmonary Exacerbation in Patients with Cystic Fibrosis-Related Diabetes/ W. Okoniewski, K. Hughan, G. Weiner, D.J. Weiner, E. Forno, Pittsburgh, PA, p.A1910 P610 Interaction Between Nutritional Status and Socioeconomic Factors at Age 2 Predicts Lung Function at Age 6 in Preschoolers with Cystic Fibrosis/ K.M. Dickinson, J.M. Collaco, K.S. Raraigh, S.M. Blackman, G.R. Cutting, K.A. Riekert, Baltimore, MD, p.A1911 P611 Barriers to Timely Diagnosis of Cystic Fibrosis Via Newborn Screening in Turkey/ Y. Gokdemir, N. Emiralioglu, T. Sismanlar, B. Er, S. Pekcan, A.P. Ergenekon, V. Sen, S. Eryilmaz, M. Gharibzadeh Hizal, M. Kose, M. Hangul, E. Cakir, H. Cokugras, A. Atabek, S. Sasihuseyinoglu, F. Gulen, A. Bingol, A. Ozdemir, E. Topal, T. Ramasli Gursoy,T. Ramasli Gursoy, P. Ay, O. Yilmaz, Istanbul, Turkey, p.A1912 P612 Cystic Fibrosis Disparities; A Tertiary Center Experience/ H. Fanous, J. Klechtermans, M. Cardenas, M. Bedoya, M. Benyamin, A.R. Colin, Miami, FL, p.A1913 P613 Ibuprofen Displays Synergistic Antibacterial Activity with Standard-of-Care Antibiotics Against Pseudomonas Aeruginosa/ Q. Chen, M.E. Ilanga, P.N. Shah, B. Chirra, S.B. Simbassa, J.A. Smolen, J.A. Tagaev, O.O. Ogun, C.L. Cannon, College Station, TX, p.A1914 P614 Is There a Role for Selected Bronchoscopy in Cystic Fibrosis?/ A. Gileles-Hillel, L. Yochi, P. Stafler, M. Mei-Zahav, M. Cohen-Cymberknoh, J. Reiter, R. Tzabari, E. Kerem, D. Shoseyov, Jerusalem, Israel, p.A1915 P615 Uncommon Organisms in Cystic Fibrosis/ C. Purdy, J. Kanyinda, A. Hahn, B. Harkness, A.C. Koumbourlis, I.R. Sami-Zakhari, Washington, DC, p.A1916 P616 Young Children with Cystic Fibrosis Have Decreased Airway Microbial Diversity Compared to Healthy Controls of Similar Age/ A. Hahn, A. Burrell, E. Ansusinha, H.R. Chaney, I.R. Sami-Zakhari, G.F. Perez, A.C. Koumbourlis, R. McCarter, R.J. Freishtat, K. Crandall, E.T. Zemanick, Washington, DC, p.A1917 P617 Prominent Intrapulmonary Bronchopulmonary Anastomoses in Children with Single Ventricle Heart Disease/ M. Di Maria, D.S. Bush, G. Morgan, S.H. Abman, C. Galambos, Aurora, CO, p.A1918 ATS 2019 • Dallas, TX SUNDAY • MAY 19 71 SUNDAY MORNING